OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Immunology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Editorial Board	133
Exploiting antifungal immunity in the clinical context	126
Differential immune responses behind different celiac disease manifestations	96
Cellular stress and macrophage activation	82
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells	75
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity	66
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer	56
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi	55
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity	53
Microbial metabolites and immunotherapy: Basic rationale and clinical indications	50
Editorial Board	50
Pyroptosis modulation by bacterial effector proteins	48
Resolving inflammatory links between myocardial infarction and vascular dementia	40
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity	39
Aging of lymphoid stromal architecture impacts immune responses	39
Immunity to pathogenic fungi in the eye	39
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)	39
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity	38
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?	38
The noncanonical inflammasome-induced pyroptosis and septic shock	36
Pyroptosis and the cellular consequences of gasdermin pores	35
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease	35
Pyroptosis: A road to next-generation cancer immunotherapy	34
Interplay between the complement system and other immune pathways in the tumor microenvironment	33
Introduction to the special issue: Neutrophils in the tumor microenvironment	31

Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment	31
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets	31
Western diet influences on microbiome and carcinogenesis	31
Immunity to fungi: Editorial overview	30
Neuroimmune interactions between itch neurons and skin microbes	28
Specialized pro-resolving mediators as modulators of immune responses	28
Cellular and molecular diversity in spondyloarthritis	28
Introduction to the Special Issue: Nanoparticles and immune responses	28
The evolving biology of cross-presentation	28
TREM2: A new player in the tumor microenvironment	26
Adaptive NK cell response to human cytomegalovirus: Facts and open issues	25
Recent developments in C3-targeted complement therapeutics	24
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases	24
The paradox of aging: Aging-related shifts in T cell function and metabolism	24
Antigen discovery for the development of cancer immunotherapy	23
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy	23
Sialic acid and Siglec receptors in tumor immunity and immunotherapy	23
The dual role of neutrophils in cancer	22
Thymus aging and immune reconstitution, progresses and challenges	22
Introduction to the Special Issue: Nutrition, microbiota and immunity	22
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases	21
T cell control of SARS-CoV-2: When, which, and where?	21
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination	20
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs	20
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic	20
Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming	20
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders	18
Introduction to the special issue: Complexity and diversity of immune responses in COVID-19	18
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity	18
Targeting the tissue-complosome for curbing inflammatory disease	18
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity	18
Publisher's note: Welcome Prof. Guido Kroemer	17
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice	17
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy	17
T cell fate decisions during memory cell generation with aging	17
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells	17
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?	17
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease	17
Promotion of trained innate immunity by nanoparticles	17
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy	16
Better safe than sorry: Naive T-cell dynamics in healthy ageing	16
Proteostasis in T cell aging	16
Global aspects of celiac disease and food allergy	15
The complement system in clinical oncology: Applications, limitations and challenges	15
Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis	15
Natural killer cell responses to human oncogenic γ-herpesvirus infections	15
Cellular and molecular heterogeneity in systemic lupus erythematosus	15
The glycoimmune landscape in health and disease	15
Identification of T cell antigens in the 21st century, as difficult as ever	15
Editorial Board	15

Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging	14
Emerging opportunities for C3 inhibition in the eye	14
The multisensory regulation of unconventional T cell homeostasis	14
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions	13
The gut-enthesis axis and the pathogenesis of Spondyloarthritis	13
Harnessing complement biomarkers for precision cancer care	13
Epigenetic and transcriptional control of gasdermins	13
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review	13
Corrigendum to “Nanoalum adjuvanted vaccines: Small details make a big difference” [Semin. Immunol. 56 (2021) 101544]	12
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond	12
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics	12
A major mechanism for immunomodulation: Dietary fibres and acid metabolites	12
Human thymus in health and disease: Recent advances in diagnosis and biology	12
Siglecs as modulators of macrophage phenotype and function	12
Unconventional protein secretion by gasdermin pores	12
Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches	12
Impact of cancer cell-intrinsic features on neutrophil behavior	12
The role of ILC subsets in cancer	11
Systems analysis of innate and adaptive immunity in Long COVID	11
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases	11
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation	11
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC	11
Microbial gasdermins: More than a billion years of pyroptotic-like cell death	11
Pyroptosis-induced inflammation and tissue damage	11
Durability of immune responses to SARS-CoV-2 infection and vaccination	11
Nanoparticles for generating antigen-specific T cells for immunotherapy	11
Nanoalum adjuvanted vaccines: small details make a big difference	10
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation	10
Reparative inflammation in multiple sclerosis	10
Polyvalent design in the cGAS-STING pathway	10
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies	10
Regulatory T cells in allergic inflammation	10
Integrating immunopeptidome analysis for the design and development of cancer vaccines	10
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond	10
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas	10
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions	10
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease	10
Current insights in mouse iNKT and MAIT cell development using single cell transcriptomics data	10
Editorial Board	10
Galectins and Host–Pathogen Interactions: The roles in viral infections	9
Complement regulation in tumor immune evasion	9
Neutrophil metabolism in the cancer context	9
The gut-brain vascular axis in neuroinflammation	8
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences	8
Immunity to fungi in the lung	8
Publisher’s Note: A change in leadership	8
The role of sialoglycans in modulating dendritic cell function and tumour immunity	8
Systems analysis of human innate immunity in COVID-19	8
The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function	8
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives	8
To die or not to die: Gasdermins in intestinal health and disease	8